{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:54:57Z","timestamp":1773089697432,"version":"3.50.1"},"reference-count":39,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,3,25]]},"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>Haemophilia is a hereditary X-linked recessive disorder caused by a deficiency of either clotting factor VIII (haemophilia A) or IX (haemophilia B). Conventional treatment is currently based on the use of either plasma derived or recombinant coagulation factors. This paper reports on the case of a patient with severe haemophilia who presented with mesial decay and interproximal tartar build-up, for which extraction and scaling to remove tartar deposits were indicated. Following extraction, the usual haemostasis techniques were applied, and postoperative prophylactic antihaemophilic treatment was indicated for 2 or 3 days. The patient presented with moderate bleeding for a few minutes immediately after the procedure. Administration of factor VIII before surgery as well as the patient\u2019s favourable pharmacokinetic response allowed for an optimal result. This treatment has afforded patients with haemophilia a better quality of life, and safe and efficient access to invasive surgical procedures.<\/jats:p>","DOI":"10.1136\/bcr-2018-227974","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T12:45:14Z","timestamp":1554727514000},"page":"e227974","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk"],"prefix":"10.1136","volume":"12","author":[{"given":"Antonio","family":"Liras","sequence":"first","affiliation":[{"name":"Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Romeu","sequence":"additional","affiliation":[{"name":"Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2025082800335287000_12.4.e227974.1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1750-1172-7-97","article-title":"Advanced therapies for the treatment of hemophilia: future perspectives","volume":"7","author":"Liras","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"2025082800335287000_12.4.e227974.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61139-2"},{"key":"2025082800335287000_12.4.e227974.3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/2040620717746312","article-title":"Novel therapies and current clinical progress in hemophilia A","volume":"9","author":"Balkaransingh","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"2025082800335287000_12.4.e227974.4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s13346-017-0365-8","article-title":"Recent advances in hemophilia B therapy","volume":"7","author":"Horava","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"2025082800335287000_12.4.e227974.5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/hae.13008","article-title":"NHF-McMaster guideline on care models for haemophilia management","volume":"22 Suppl 3","author":"Pai","year":"2016","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b705"},{"key":"2025082800335287000_12.4.e227974.7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1160\/TH10-02-0096","article-title":"Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis","volume":"104","author":"Lederman","year":"2010","journal-title":"Thromb Haemost"},{"key":"2025082800335287000_12.4.e227974.8","first-page":"279","article-title":"Emerging viral infections\u2011-a potential threat for blood supply in the 21st century","volume":"14","author":"de Mendoza","year":"2012","journal-title":"AIDS Rev"},{"key":"2025082800335287000_12.4.e227974.9","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/trf.14145","article-title":"Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk","volume":"57","author":"Crowder","year":"2017","journal-title":"Transfusion"},{"key":"2025082800335287000_12.4.e227974.10","first-page":"35","article-title":"Hepatitis C infection in patients with hereditary bleeding disorders: epidemiology, natural history, and management","volume":"31","author":"Papadopoulos","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"2025082800335287000_12.4.e227974.11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/hae.12683","article-title":"Transition considerations for extended half-life factor products","volume":"21","author":"Croteau","year":"2015","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jocs.13530","article-title":"Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B","volume":"33","author":"Kanellopoulou","year":"2018","journal-title":"J Card Surg"},{"key":"2025082800335287000_12.4.e227974.13","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/hae.12919","article-title":"Surgical procedures in patients with haemophilic arthropathy of the ankle","volume":"22","author":"Barg","year":"2016","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/hae.13122","article-title":"Risk-based management of dental procedures in patients with inherited bleeding disorders: development of a dental bleeding risk assessment and treatment tool (DeBRATT)","volume":"23","author":"Rasaratnam","year":"2017","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653759"},{"key":"2025082800335287000_12.4.e227974.16","first-page":"869","article-title":"Letter: A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"2025082800335287000_12.4.e227974.17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0037-1615080","article-title":"A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII\/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis","volume":"79","author":"Giles","year":"1998","journal-title":"Thromb Haemost"},{"key":"2025082800335287000_12.4.e227974.18","doi-asserted-by":"crossref","first-page":"042","DOI":"10.1055\/s-0038-1648376","article-title":"Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test","volume":"67","author":"Tripodi","year":"1992","journal-title":"Thromb Haemost"},{"key":"2025082800335287000_12.4.e227974.19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00001721-199312000-00006","article-title":"Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin","volume":"4","author":"van den Besselaar","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2025082800335287000_12.4.e227974.20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2257.1989.tb00212.x","article-title":"A comparison of two APTT reagents which use silica activators","volume":"11","author":"Ray","year":"1989","journal-title":"Clin Lab Haematol"},{"key":"2025082800335287000_12.4.e227974.21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13375"},{"key":"2025082800335287000_12.4.e227974.22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ijlh.12813","article-title":"New challenges and best practices for the laboratory monitoring of factor VIII and factor IX replacement","volume":"40 Suppl 1","author":"Van den Bossche","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"2025082800335287000_12.4.e227974.23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1076029617715117","article-title":"Major and minor classifications for surgery in people with hemophilia: a literature review","volume":"24","author":"Solimeno","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"2025082800335287000_12.4.e227974.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02329.x"},{"key":"2025082800335287000_12.4.e227974.25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.thromres.2010.11.030","article-title":"Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate(\u00ae), in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients","volume":"127","author":"Klukowska","year":"2011","journal-title":"Thromb Res"},{"key":"2025082800335287000_12.4.e227974.26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/hae.12075","article-title":"No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study","volume":"19","author":"Auerswald","year":"2013","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.27","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12419"},{"key":"2025082800335287000_12.4.e227974.28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/hae.12839","article-title":"Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme","volume":"22","author":"Oldenburg","year":"2016","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/scd.12189","article-title":"Access to dental care for people with bleeding disorders: survey results of hemophilia treatment centers in the U.S","volume":"36","author":"Schaffer","year":"2016","journal-title":"Spec Care Dentist"},{"key":"2025082800335287000_12.4.e227974.30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/hae.13549","article-title":"Recommendations on multidisciplinary management of elective surgery in people with haemophilia","volume":"24","author":"Escobar","year":"2018","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.31","first-page":"56","article-title":"Dental management of patients with inherited bleeding disorders: a multidisciplinary approach","volume":"65","author":"Abed","year":"2017","journal-title":"Gen Dent"},{"key":"2025082800335287000_12.4.e227974.32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd.2018.70","article-title":"Advances and innovations in haemophilia treatment","volume":"17","author":"Peters","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2025082800335287000_12.4.e227974.33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/hae.13507","article-title":"Bioengineered molecules for the management of haemophilia: Promise and remaining challenges","volume":"24 Suppl 6","author":"Pipe","year":"2018","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/hae.13510","article-title":"Emerging therapies for haemophilia - Global perspective","volume":"24 Suppl 6","author":"Mahlangu","year":"2018","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/hae.13519","article-title":"Miracle of haemophilia drugs: Personal views about a few main players","volume":"24","author":"Mannucci","year":"2018","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/hae.13489","article-title":"Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes","volume":"24","author":"Pierce","year":"2018","journal-title":"Haemophilia"},{"key":"2025082800335287000_12.4.e227974.37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14740338.2019.1574743","article-title":"Safety of recombinant coagulation factors in treating hemophilia","volume":"18","author":"Morfini","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"2025082800335287000_12.4.e227974.38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/scd.12359","article-title":"U.K. hemophilia treaters' knowledge of risk assessment for prolonged bleeding associated with dental procedures","volume":"39","author":"Rahman","year":"2019","journal-title":"Spec Care Dentist"},{"key":"2025082800335287000_12.4.e227974.39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/hae.13678","article-title":"Parent\u2019s report on oral health-related quality of life of children with haemophilia","volume":"25","author":"Yazicioglu","year":"2019","journal-title":"Haemophilia"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-227974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:34:01Z","timestamp":1756366441000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-227974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1136\/bcr-2018-227974"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-227974","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}